相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neopterin, a prognostic marker in human malignancies
Robert Sucher et al.
CANCER LETTERS (2010)
Bioavailability of Interferon-beta in patients with multiple sclerosis - fishing for the surrogate
B. C. Kieseier et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Effect of neutralizing antibodies on biomarker responses to interferon beta The INSIGHT study
Andrew R. Pachner et al.
NEUROLOGY (2009)
Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine
Francesco Matrisciano et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Interferon-beta responders and non-responders. A biological approach
Antonio Bertolotto et al.
NEUROLOGICAL SCIENCES (2008)
Predictive markers for response to interferon therapy in patients with multiple sclerosis
S. Malucchi et al.
NEUROLOGY (2008)
Tryptophan degradation in autoimmune diseases
C. A. Opitz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies
Carolina Scagnolari et al.
JOURNAL OF NEUROLOGY (2007)
Indoleamine-2,3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection
Katharina Schroecksnadel et al.
CURRENT DRUG METABOLISM (2007)
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
L. Kappos et al.
NEUROLOGY (2006)
Therapeutic role of beta-interferons in multiple sclerosis
A Javed et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Monitoring tryptophan metabolism in chronic immune activation
K Schröcksnadel et al.
CLINICA CHIMICA ACTA (2006)
Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1
F Gilli et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Interferon-β affects the tryptophan metabolism in multiple sclerosis patients
A Amirkhani et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections
O Adams et al.
JOURNAL OF VIROLOGY (2004)
Neutralizing antibodies against IFN-β in multiple sclerosis:: antagonization of IFN-β mediated suppression of MMPs
F Gilli et al.
BRAIN (2004)
Is serum neopterin level a marker of responsiveness to interferon beta-1a therapy in multiple sclerosis?
F Casoni et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis
F Bagnato et al.
NEUROLOGICAL SCIENCES (2003)
Neopterin as a marker for immune system activation
C Murr et al.
CURRENT DRUG METABOLISM (2002)
Complex immunomodulatory effects of interferon-β in multiple sclerosis include the upregulation of T helper 1-associated marker genes
KP Wandinger et al.
ANNALS OF NEUROLOGY (2001)
The neutralization of interferons by antibody. I. Quantitative and theoretical analyses of the neutralization reaction in different bioassay systems
SE Grossberg et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
The neutralization of interferons by antibody. II. Neutralizing antibody unitage and its relationship to bioassay sensitivity: The tenfold reduction unit
SE Grossberg et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Interferon-β1a administration results in a transient increase of serum amyloid A protein and C-reactive protein:: comparison with other markers of inflammation
MT Boylan et al.
IMMUNOLOGY LETTERS (2001)
分享论文
